Literature DB >> 8221580

The American Joint Committee on Cancer. Criteria for prognostic factors and for an enhanced prognostic system.

H B Burke1, D E Henson.   

Abstract

The American Joint Committee on Cancer proposes the following criteria for evaluating putative prognostic factors: they must be (1) significant, (2) independent, and (3) clinically important. Furthermore, we suggest the criteria for selecting a prognostic system that includes TNM and new prognostic factors. These criteria are: (1) easy for physicians to use; (2) provides predictions for all types of cancer; (3) provides the most accurate relapse and survival predictions at diagnosis and for every year lived for each patient; (4) provides group survival curves, where the grouping can be by any variable including outcome and therapy; (5) accommodates missing data and censored patients and is tolerant of noisy and biased data; (6) makes no a priori assumptions regarding the type of data, the distribution of the variables, or the relationships among the variables; (7) can test putative prognostic factors for significance, independence, and clinical importance; (8) accommodates treatment information in the evaluation of prognostic factors; (9) accommodates new putative prognostic factors without changing the model; (10) accommodates emerging diagnostic techniques; (11) provides information regarding the importance of each predictive variable; and (12) is automatic.

Entities:  

Mesh:

Year:  1993        PMID: 8221580     DOI: 10.1002/1097-0142(19931115)72:10<3131::aid-cncr2820721039>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Validation of the QTNM staging system for cancer-specific survival in patients with differentiated thyroid cancer.

Authors:  Daniel Mankarios; Peter Baade; Pip Youl; Robin H Mortimer; Adedayo A Onitilo; Anthony Russell; Suhail A R Doi
Journal:  Endocrine       Date:  2013-10-31       Impact factor: 3.633

Review 2.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  The anatomy of the TNM for colon cancer.

Authors:  Donald E Henson; Matthew T Hueman; Dechang Chen; Jigar A Patel; Huan Wang; Arnold M Schwartz
Journal:  J Gastrointest Oncol       Date:  2017-02

4.  Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma.

Authors:  M C Uygur; A Usubütün; H Ozen; A Ayhan; S Kendi
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 5.  Are Survival Outcomes Different for Young and Old Patients with Oral and Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis.

Authors:  Swagatika Panda; Neeta Mohanty; Saurav Panda; Lora Mishra; Divya Gopinath; Alkananda Sahoo; Sumanth Kumbargere Nagraj; Barbara Lapinska
Journal:  Cancers (Basel)       Date:  2022-04-08       Impact factor: 6.575

6.  Can survival prediction be improved by merging gene expression data sets?

Authors:  Haleh Yasrebi; Peter Sperisen; Viviane Praz; Philipp Bucher
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

7.  Multivariate evaluation of prognostic determinants for renal cell carcinomas which are metastatic at initial diagnosis.

Authors:  M Takashi; T Kawai; T Murase; K Wakai; Y Ohno
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

8.  On an ensemble algorithm for clustering cancer patient data.

Authors:  Ran Qi; Dengyuan Wu; Li Sheng; Donald Henson; Arnold Schwartz; Eric Xu; Kai Xing; Dechang Chen
Journal:  BMC Syst Biol       Date:  2013-10-23

9.  REporting recommendations for tumour MARKer prognostic studies (REMARK).

Authors:  L M McShane; D G Altman; W Sauerbrei; S E Taube; M Gion; G M Clark
Journal:  Br J Cancer       Date:  2005-08-22       Impact factor: 7.640

10.  The sirtuin 3 expression profile is associated with pathological and clinical outcomes in colon cancer patients.

Authors:  Chunyuan Liu; Zonghai Huang; Hong Jiang; Fujun Shi
Journal:  Biomed Res Int       Date:  2014-07-01       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.